Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Dexmedetomidine vs. Tramadol With Ropivacaine in Ultrasound-Guided PENG Block for Hip Surgery

To compare the mean onset of sensory block and mean time to first rescue analgesia between ropivacaine with dexmedetomidine and ropivacaine with tramadol in ultrasound-guided pericapsular nerve group block for postoperative analgesia in patients undergoing hip surgeries.

Participants needed: 66
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Sargodha Medical CollegeUpdated: Oct 7, 2026Locations: 1
Eligibility criteria

Patients aged 18 to 65years [+3]

Known allergy to ropivacaine,dexmedetomidine,tramadol,ketorolac or bupivacaine [+8]

Status: Not yet recruiting

Unilateral Spinal Anesthesia vs Popliteal-Adductor Canal Block for Below-knee Amputation

To compare the mean duration of postoperative analgesia between unilateral spinal anaesthesia and combined popliteal sciatic nerve block with adductor canal block in diabetic patients undergoing below-knee amputation.

Participants needed: 68
Trial details
Age: 40-70Biological sex: AllType: InterventionalSponsor: Sargodha Medical CollegeUpdated: Oct 2, 2026Locations: 1
Eligibility criteria

Adults aged 40 to 75 years, of either gender. [+2]

Documented allergy to amide local anaesthetics. [+4]

Status: Not yet recruiting

Magnesium Sulphate for Neonatal Asphyxia and Length of Hospital Stay

Neonatal asphyxia causes significant global morbidity, frequently resulting in Hypoxic-Ischemic Encephalopathy (HIE). In resource-limited settings where therapeutic hypothermia is unavailable, affordable neuroprotective options are needed. Intravenous magnesium sulphate blocks NMDA receptors, limiting cellular calcium influx and neuroinflammation. This randomized controlled trial evaluates whether adjuvant intravenous magnesium sulphate (250\\text{ mg/kg} within 6 hours of birth) reduces the duration of hospital stay and improves short-term clinical outcomes in term neonates with birth asphyxia.

Participants needed: 72
Trial details
Age: Up to 24Biological sex: AllType: InterventionalSponsor: Sargodha Medical CollegeUpdated: Sep 23, 2026
Eligibility criteria

Term neonates (gestational age more than 37 weeks), [+2]

Major congenital anomalies [+3]